ADR Sign up for ETOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TeKoppele, J.
Right arrow Articles by Bank, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TeKoppele, J.
Right arrow Articles by Bank, R.
Advances in Dental Research, Vol 12, Issue 2, 63-67
Copyright © 1998 by International & American Associations for Dental Research


Articles

Doxycycline inhibits collagen synthesis by differentiated articular chondrocytes

JM TeKoppele, B Beekman, N Verzijl, JL Koopman, J DeGroot, and RA Bank

Gaubius Laboratory, TNO Prevention and Health, Leiden, The Netherlands.

Doxycycline (DOX) profoundly inhibited collagen synthesis by differentiated articular chondrocytes. At 25 microM, the rate of collagen synthesis was suppressed by more than 50% without affecting cell proliferation (DNA levels) and general protein synthesis (35S-Met and 35S-Cys incorporation). Steady-state mRNA levels of type II collagen were also reduced, indicating that DOX may have an effect at the transcriptional level of type II collagen. The IC50 value of DOX to downregulate collagen synthesis (17 microM) is close to DOX levels attained in vivo (< 10 microM), and it is more than ten-fold lower than the IC50 values to inhibit the activity of most matrix metalloproteinases (MMPs). As such, these findings support the hypothesis that the reduced severity of OA observed in the dog anterior cruciate ligament model resulting from prophylactic treatment with DOX may involve mechanisms other than MMP inhibition alone. Our findings suggest that prevention of changes in the chondrocyte phenotype may be involved in the beneficial effect of doxycycline in experimental osteoarthritis, for differentiated chondrocytes in early stages of osteoarthritis exhibit elevated collagen synthesis.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
C. Franco, B. Ho, D. Mulholland, G. Hou, M. Islam, K. Donaldson, and M. P. Bendeck
Doxycycline Alters Vascular Smooth Muscle Cell Adhesion, Migration, and Reorganization of Fibrillar Collagen Matrices
Am. J. Pathol., May 1, 2006; 168(5): 1697 - 1709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. M. Islam, C. D. Franco, D. W. Courtman, and M. P. Bendeck
A Nonantibiotic Chemically Modified Tetracycline (CMT-3) Inhibits Intimal Thickening
Am. J. Pathol., October 1, 2003; 163(4): 1557 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. P. Bendeck, M. Conte, M. Zhang, N. Nili, B. H. Strauss, and S. M. Farwell
Doxycycline Modulates Smooth Muscle Cell Growth, Migration, and Matrix Remodeling after Arterial Injury
Am. J. Pathol., March 1, 2002; 160(3): 1089 - 1095.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 1998 Institutional Access Guidelines